Coregistered FDG-PET and CT imaging can effectively identify and characterize pericardial and epicardial involvement in patients with non-Hodgkin lymphoma.
Answers are grounded in this paper and cite their sources.
May aid staging of non-Hodgkin lymphoma with pericardial involvement; leaves open routine diagnostic role pending larger studies.
An 80-year-old man with a previous myocardial infarct, presented with malaise, weight loss, fever, night sweating, dyspnoea, and bilateral pleural effusion. Cardiac echo revealed a 3 cm pericardial effusion without signs of tamponade and a left ventricular ejection fraction of 60%. After transbronchial biopsy and pleural effusion cytology, large-cell B-cell non-Hodgkin lymphoma was diagnosed. A whole-body, baseline, FDG-PET scan showed extensive disease with mediastinal, supra- and infraclavicular, abdominal, and splenic lesions (stage IVB). Right pleural involvement was also evident. The most striking finding was massive heart enlargement with diffusely increased uptake (Panel A). Transversal CT section at heart level (Panel C) showed cardiac enlargement, pericardial and epicardial (lamina visceralis) thickening as well as pericardial and pleural effusion, more prominent on the right. The corresponding FDG-PET section revealed intense pericardial–epicardial hypermetabolism (arrows) and increased pleural uptake on the right (Panel D). Anatomical characterization of hypermetabolic sites was confirmed by fused FDG-PET/CT images (Panel E).
No takes yet. Share an insight, caveat, or question.
Weijs et al. (2007) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: